Heavy Ion Therapy Research Integration plus

The EU-funded HITRIplus project aims to integrate and propel biophysics and medical research on cancer treatment with heavy ions beams while jointly developing its sophisticated instruments. The wider objective of HITRIplus is to provide radiation oncologists with a cutting-edge tool to treat the tumours that are not curable with X-rays or protons or have better survival rates with ions. Transnational access will integrate and open the European facilities providing therapeutic ion beams to external researchers and clinicians. Networks will structure and foster the research on heavy ion therapy, including clinical and pre-clinical research. Joint research activities will develop new accelerator and beam delivery technologies to extend the reach of the present generation centres to make cancer ion therapy more accessible.